Evidence map›Paper›PMID 36615470›Full record

ReviewMolecules (Basel, Switzerland)2022

Nanostructures as Photothermal Agents in Tumor Treatment.

Yuqian Chen, Futing Zhou, Chenshuai Wang, Linlin Hu, Pengfei Guo

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Multifunctional BiInternational journal of pharmaceutics: X · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. PLGA and PDMS-basedFrontiers in pharmacology · 2024
    Article
  15. Review
  16. The Therapeutic Effects of MUC1-C shRNA@FeInternational journal of nanomedicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuqian ChenSchool of Pharmacy, Weifang Medical University, Weifang 261053, China.ORCID 0000-0002-0415-7537
Futing ZhouFangcheng Street Hospital, Weifang 261200, China.
Chenshuai WangSchool of Life Science and Technology, Weifang Medical University, Weifang 261053, China.
Linlin HuSchool of Pharmacy, Weifang Medical University, Weifang 261053, China.ORCID 0000-0002-4464-3695
Pengfei GuoSchool of Pharmacy, Weifang Medical University, Weifang 261053, China.

Funding

Natural Science Foundation of Shandong Province Youth Project ZR2022QB024Startup Fund granted by Weifang Medical University 04112301Traditional Chinese Medicine Science and Technology Project of Shandong Province 2020Q056
6 · The paper itself

Abstract

Traditional methods of tumor treatment such as surgical resection, chemotherapy, and radiation therapy have certain limitations, and their treatment effects are not always satisfactory. As a new tumor treatment method, photothermal therapy based on nanostructures has attracted the attention of researchers due to its characteristics of minimally invasive, low side effects, and inhibition of cancer metastasis. In recent years, there has been a variety of inorganic or organic nanostructures used in the field of photothermal tumor treatment, and they have shown great application prospects. In this paper, the advantages and disadvantages of a variety of nanomaterials/nanostructures as photothermal agents (PTAs) for photothermal therapy as well as their research progress are reviewed. For the sake of clarity, the recently reported nanomaterials/nanostructures for photothermal therapy of tumor are classified into five main categories, i.e., carbon nanostructures, noble metal nanostructures, transition metal sulfides, organic polymer, and other nanostructures. In addition, future perspectives or challenges in the related field are discussed.

Indexed as

Hyperthermia, InducedNanostructuresNeoplasmsTransition ElementsHumansPhototherapyTransition Elementsnanomaterialsnanostructuresphotothermal agentsphotothermal therapytumor

Identifiers

PMID36615470
PMCPMC9822183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.